However, given the fact that the Q192R polymorphism strongly affects lifelong PON1-activity, the absence of a relation between the Q192R polymorphism and CAD risk suggests that PON1-activity is not a causal factor in atherogenesis. Here, PON1 is linked to coronary artery disorder.